Glucose Health (OTCMKTS:GLUC – Get Free Report) and Curaleaf (OTCMKTS:CURLF – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, valuation and earnings.
Risk and Volatility
Glucose Health has a beta of 3.56, meaning that its stock price is 256% more volatile than the S&P 500. Comparatively, Curaleaf has a beta of 0.88, meaning that its stock price is 12% less volatile than the S&P 500.
Valuation & Earnings
This table compares Glucose Health and Curaleaf’s top-line revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Glucose Health | N/A | N/A | N/A | N/A | N/A |
Curaleaf | $1.35 billion | 1.52 | -$281.20 million | ($0.39) | -8.08 |
Profitability
This table compares Glucose Health and Curaleaf’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Glucose Health | N/A | N/A | N/A |
Curaleaf | -20.29% | -14.43% | -5.20% |
Insider & Institutional Ownership
0.0% of Curaleaf shares are held by institutional investors. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Analyst Ratings
This is a summary of recent ratings for Glucose Health and Curaleaf, as reported by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Glucose Health | 0 | 0 | 0 | 0 | N/A |
Curaleaf | 0 | 0 | 1 | 0 | 3.00 |
Curaleaf has a consensus target price of $6.25, indicating a potential upside of 98.41%. Given Curaleaf’s higher probable upside, analysts plainly believe Curaleaf is more favorable than Glucose Health.
About Glucose Health
Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. The company was formerly known as Bio-Solutions Corp. and changed its name to Glucose Health, Inc. in November 2014. Glucose Health, Inc. was incorporated in 2007 and is based in Bentonville, Arkansas.
About Curaleaf
Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. The company is headquartered in New York, New York.
Receive News & Ratings for Glucose Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Glucose Health and related companies with MarketBeat.com's FREE daily email newsletter.